Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immune plasma for the treatment of severe influenza: an open-label, multicentre, phase 2 randomised study.
Beigel JH, Tebas P, Elie-Turenne MC, Bajwa E, Bell TE, Cairns CB, Shoham S, Deville JG, Feucht E, Feinberg J, Luke T, Raviprakash K, Danko J, O'Neil D, Metcalf JA, King K, Burgess TH, Aga E, Lane HC, Hughes MD, Davey RT; IRC002 Study Team. Beigel JH, et al. Among authors: raviprakash k. Lancet Respir Med. 2017 Jun;5(6):500-511. doi: 10.1016/S2213-2600(17)30174-1. Epub 2017 May 15. Lancet Respir Med. 2017. PMID: 28522352 Free PMC article. Clinical Trial.
Safety and tolerability of a novel, polyclonal human anti-MERS coronavirus antibody produced from transchromosomic cattle: a phase 1 randomised, double-blind, single-dose-escalation study.
Beigel JH, Voell J, Kumar P, Raviprakash K, Wu H, Jiao JA, Sullivan E, Luke T, Davey RT Jr. Beigel JH, et al. Among authors: raviprakash k. Lancet Infect Dis. 2018 Apr;18(4):410-418. doi: 10.1016/S1473-3099(18)30002-1. Epub 2018 Jan 9. Lancet Infect Dis. 2018. PMID: 29329957 Free PMC article. Clinical Trial.
Anti-influenza immune plasma for the treatment of patients with severe influenza A: a randomised, double-blind, phase 3 trial.
Beigel JH, Aga E, Elie-Turenne MC, Cho J, Tebas P, Clark CL, Metcalf JP, Ozment C, Raviprakash K, Beeler J, Holley HP Jr, Warner S, Chorley C, Lane HC, Hughes MD, Davey RT Jr; IRC005 Study Team. Beigel JH, et al. Among authors: raviprakash k. Lancet Respir Med. 2019 Nov;7(11):941-950. doi: 10.1016/S2213-2600(19)30199-7. Epub 2019 Sep 30. Lancet Respir Med. 2019. PMID: 31582360 Free PMC article. Clinical Trial.
Influence of sample collection tube method, anticoagulant-containing plasma versus serum, on influenza virus hemagglutination inhibition titer and microneutralization titer serological assays.
Morrison BJ, Martin NJ, Rehman T, Ewing D, Dewar RL, Metcalf J, Sun P, Beigel J, Luke TC, Raviprakash K. Morrison BJ, et al. Among authors: raviprakash k. BMC Health Serv Res. 2018 Aug 22;18(1):651. doi: 10.1186/s12913-018-3465-3. BMC Health Serv Res. 2018. PMID: 30134892 Free PMC article.
Antibody-dependent NK cell degranulation as a marker for assessing antibody-dependent cytotoxicity against pandemic 2009 influenza A(H1N1) infection in human plasma and influenza-vaccinated transchromosomic bovine intravenous immunoglobulin therapy.
Morrison BJ, Roman JA, Luke TC, Nagabhushana N, Raviprakash K, Williams M, Sun P. Morrison BJ, et al. Among authors: raviprakash k. J Virol Methods. 2017 Oct;248:7-18. doi: 10.1016/j.jviromet.2017.06.007. Epub 2017 Jun 15. J Virol Methods. 2017. PMID: 28624584 Free PMC article.
Safety and Immunogenicity of a Tetravalent Dengue DNA Vaccine Administered with a Cationic Lipid-Based Adjuvant in a Phase 1 Clinical Trial.
Danko JR, Kochel T, Teneza-Mora N, Luke TC, Raviprakash K, Sun P, Simmons M, Moon JE, De La Barrera R, Martinez LJ, Thomas SJ, Kenney RT, Smith L, Porter KR. Danko JR, et al. Among authors: raviprakash k. Am J Trop Med Hyg. 2018 Mar;98(3):849-856. doi: 10.4269/ajtmh.17-0416. Epub 2018 Jan 18. Am J Trop Med Hyg. 2018. PMID: 29363446 Free PMC article. Clinical Trial.
Evaluation of a prototype dengue-1 DNA vaccine in a Phase 1 clinical trial.
Beckett CG, Tjaden J, Burgess T, Danko JR, Tamminga C, Simmons M, Wu SJ, Sun P, Kochel T, Raviprakash K, Hayes CG, Porter KR. Beckett CG, et al. Among authors: raviprakash k. Vaccine. 2011 Jan 29;29(5):960-8. doi: 10.1016/j.vaccine.2010.11.050. Epub 2010 Nov 25. Vaccine. 2011. PMID: 21111785 Clinical Trial.
Self-administration of intranasal influenza vaccine: Immunogenicity and volunteer acceptance.
Burgess TH, Murray CK, Bavaro MF, Landrum ML, O'Bryan TA, Rosas JG, Cammarata SM, Martin NJ, Ewing D, Raviprakash K, Mor D, Zell ER, Wilkins KJ, Millar EV. Burgess TH, et al. Among authors: raviprakash k. Vaccine. 2015 Jul 31;33(32):3894-9. doi: 10.1016/j.vaccine.2015.06.061. Epub 2015 Jun 25. Vaccine. 2015. PMID: 26117150 Free PMC article. Clinical Trial.
Advances in dengue vaccine development.
Raviprakash K, Defang G, Burgess T, Porter K. Raviprakash K, et al. Hum Vaccin. 2009 Aug;5(8):520-8. doi: 10.4161/hv.5.8.9008. Epub 2009 Aug 13. Hum Vaccin. 2009. PMID: 19535912 Review.
52 results